Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada flag Canada · Delayed Price · Currency is CAD
12.40
-0.02 (-0.16%)
Sep 5, 2025, 3:59 PM EDT

Fennec Pharmaceuticals Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
346250400341145245
Upgrade
Market Cap Growth
36.83%-37.55%17.23%135.62%-40.89%46.29%
Upgrade
Enterprise Value
347238418334120203
Upgrade
Last Close Price
12.408.8715.1613.095.609.09
Upgrade
PS Ratio
7.633.6514.25164.24-1131.07
Upgrade
PB Ratio
-34.04-29.57-26.06-98.137.266.61
Upgrade
P/TBV Ratio
----7.266.61
Upgrade
P/OCF Ratio
-6.44----
Upgrade
EV/Sales Ratio
7.543.4814.88160.94-935.98
Upgrade
EV/EBITDA Ratio
-45.94----
Upgrade
EV/EBIT Ratio
-64.41----
Upgrade
Debt / Equity Ratio
-2.59-3.29-2.66-9.690.32-
Upgrade
Debt / EBITDA Ratio
-5.37----
Upgrade
Asset Turnover
0.621.320.790.06-0.01
Upgrade
Inventory Turnover
1.551.980.92---
Upgrade
Quick Ratio
4.305.712.925.4912.7612.93
Upgrade
Current Ratio
4.856.383.565.8013.5413.39
Upgrade
Return on Equity (ROE)
----359.22%-77.36%-88.45%
Upgrade
Return on Assets (ROA)
-11.20%4.47%-29.67%-57.21%-39.99%-49.07%
Upgrade
Return on Capital (ROIC)
-28.57%9.79%-38.32%-65.53%-43.20%-54.60%
Upgrade
Return on Capital Employed (ROCE)
-6.80%----
Upgrade
Earnings Yield
-4.74%-0.25%-5.30%-9.41%-15.16%-9.42%
Upgrade
Buyback Yield / Dilution
3.63%-2.71%-1.14%-1.03%-9.71%-19.14%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.